Dr Alicia Fajardo Lubián
Postdoctoral Researcher / Research Coordinator
Bachelor in Biochemistry 2004, PhD Molecular Biology 2009 and MSc in Clinical Trials Monitoring 2012
alicia.fajardolubian@wimr.org.au
Biography
During Dr. Fajardo Lubian’s PhD and early postdoctoral training (2004-2012, National Centre for Biotechnology, Spain), she specialised in antimicrobial resistance (AMR), with a focus on the genetic basis of Pseudomonas aeruginosa antibiotic resistance and the links between resistance and virulence.
Since March 2013, Dr. Fajardo Lubian has worked within Iredell’s team (The University of Sydney and the Westmead Institute for Medical Research) on projects investigating AMR in gram-negative bacteria and evaluating complementary approaches to antibiotics for the treatment of multidrug-resistant infections.
Research interests
Dr. Fajardo Lubian’s research focuses on antimicrobial resistance (AMR) and the evolution of clinically relevant drug-resistant pathogens, with the goal of informing improved diagnostic and therapeutic solutions. Her work spans two main areas: (1) AMR surveillance and genetic epidemiology, identifying priority AMR genes and high-risk resistant clones circulating in Australia; and (2) novel antimicrobial therapies, including phage- and plasmid-based approaches and their translation to clinical application.
– Genetic analysis of antimicrobial-resistant gram-negative pathogens as part of the Australia’s national AMR surveillance program for Gram-negative bacteria (AGAR GnSOP; https://agargroup.org.au/; funded by the Australian Government Department of Health, Disability and Ageing).
– Novel antimicrobial therapies (plasmid therapy), with a focus on characterising AMR plasmids and developing rapid diagnostics by designing assays that define AMR gene-plasmid associations.
– Novel antimicrobial therapies (phage research), with a focus on characterising phage-host interactions to support phage therapy applications against multidrug-resistant and intracellular pathogens (e.g., P. aeruginosa, E. coli, K. pneumoniae, Shigella spp.).
Additional information
Alternative Email – alicia.fajardolubian@sydney.edu.au
